Bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and irinotecan for treatment of malignant gliomas.

Conference Paper

Full Text

Link to Item

Duke Authors

Cited Authors

Vredenburgh, JJ; Desjardins, A; II, HJE; Quinn, J; Rich, J; Sathornsumetee, S; Friedman, HS; Reardon, D; Gururangan, S; Friedman, A

Published Date

June 20, 2006

Published In

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Volume / Issue

24 / 18

Start / End Page

59S - 59S

International Standard Serial Number (ISSN)

0732-183X